<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sost" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sost</book-part-id>
      <title-group>
        <title><italic toggle="yes">SOST</italic>-Related Sclerosing Bone Dysplasias</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Beighton</surname>
            <given-names>Peter H</given-names>
          </name>
          <xref ref-type="aff" rid="sost.AFF1"/>
          <degrees>MD, PhD, FRCP, FRCPCH, FRSSA</degrees>
          <email>Peter.Beighton@uct.ac.za</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Hamersma</surname>
            <given-names>Herman</given-names>
          </name>
          <xref ref-type="aff" rid="sost.AFF2"/>
          <degrees>MD</degrees>
          <email>hamersmah@surgeon.co.za</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Brunkow</surname>
            <given-names>Mary E</given-names>
          </name>
          <xref ref-type="aff" rid="sost.AFF3"/>
          <degrees>PhD</degrees>
          <email>mary.brunkow@systemsbiology.org</email>
        </contrib>
      </contrib-group>
      <aff id="sost.AFF1">Division of Human Genetics<break/>Faculty of Health Sciences<break/>University of Cape Town<break/>Cape Town, South Africa</aff>
      <aff id="sost.AFF2">Otolaryngologist<break/>Flora Clinic<break/>Roodepoort, South Africa</aff>
      <aff id="sost.AFF3">Institute for Systems Biology<break/>Seattle, Washington</aff>
      <pub-history>
        <date iso-8601-date="2002-06-04" date-type="created">
          <day>04</day>
          <month>06</month>
          <year>2002</year>
        </date>
        <date iso-8601-date="2012-01-12" date-type="updated">
          <day>12</day>
          <month>01</month>
          <year>2012</year>
        </date>
        <date iso-8601-date="2013-01-10" date-type="revised">
          <day>10</day>
          <month>01</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="slc6a3-dtds" document-type="chapter"><italic toggle="yes">SLC6A3</italic>-Related Dopamine Transporter Deficiency Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="sox2" document-type="chapter">
<italic toggle="yes">SOX2</italic>-Related Eye Disorders</related-object>
      <abstract id="sost.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias include sclerosteosis and van Buchem disease; both are disorders of osteoblast hyperactivity. The major clinical features of sclerosteosis are progressive skeletal overgrowth and variable syndactyly, usually of the second (index) and third (middle) fingers. Affected individuals appear normal at birth except for syndactyly. Distinctive facial features including asymmetric mandibular hypertrophy, frontal bossing, and midface hypoplasia are usually apparent by mid-childhood. Hyperostosis of the skull results in narrowing of the foramina, causing entrapment of the seventh cranial nerve (often leading to facial palsy) and entrapment of the eighth cranial nerve (often resulting in deafness in mid-childhood). In sclerosteosis, hyperostosis of the calvarium reduces intracranial volume, increasing the risk for potentially lethal elevation of intracranial pressure. Survival of individuals with sclerosteosis into old age is unusual. The manifestations of van Buchem disease are generally milder than sclerosteosis and syndactyly is absent. Based on a few case reports, it is also likely that the spectrum of <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias includes an autosomal dominant form of craniodiaphyseal dysplasia (CDD).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnoses of sclerosteosis and van Buchem disease are based on recognition of the characteristic clinical and radiographic features. Radiographic findings include widening (hyperostosis) and increased density (sclerosis) of the calvarium, the base of the skull, and the shafts of the tubular bones. <italic toggle="yes">SOST</italic> is the only gene known to be associated with sclerosteosis and van Buchem disease. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Surgical decompression of entrapped cranial nerves, notably the facial nerve; craniectomy for increased intracranial pressure; middle ear surgery for conductive hearing loss; hearing aids; spinal cord decompression for backache; surgical correction of syndactyly; surgical reduction of mandibular overgrowth. </p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Tooth extraction may be difficult; management by an orthodontic or craniofacial team is recommended. </p>
          <p><italic toggle="yes">Surveillance</italic>: Annual assessments from infancy for hearing, evidence of increased intracranial pressure, and evidence of cranial nerve entrapment. </p>
          <p><italic toggle="yes">Evaluation of relatives at risk</italic>: Clinical appraisal, lateral skull radiograph if indicated; molecular genetic testing of the parents if the <italic toggle="yes">SOST</italic> mutations have been identified in the proband.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias are inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Prenatal diagnosis for pregnancies at increased risk for the <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias is possible if the disease-causing mutations in the family have been identified. Ultrasound examination may detect syndactyly, but its absence on ultrasound examination does not rule out an affected fetus. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sost.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="sost.T.nc_sostrelated_sclerosing_bone_dy" position="anchor" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <th id="hd_b_sost.T.nc_sostrelated_sclerosing_bone_dy_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">SOST</italic>-Related Sclerosing Bone Dysplasias: Included Disorders</th>
              </tr>
              <tr>
                <td headers="hd_b_sost.T.nc_sostrelated_sclerosing_bone_dy_1_1_1_1" align="left" valign="top" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Sclerosteosis</p>
                    </list-item>
                    <list-item>
                      <p>van Buchem disease</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="sost.TF.1">
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="sost.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sost.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sost.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Sclerosteosis and van Buchem disease are clinically and radiographically similar disorders that are caused by mutations in <italic toggle="yes">SOST</italic> [<xref ref-type="bibr" rid="sost.REF.balemans.2001.537">Balemans et al 2001</xref>, <xref ref-type="bibr" rid="sost.REF.brunkow.2001.577">Brunkow et al 2001</xref>, <xref ref-type="bibr" rid="sost.REF.balemans.2002b.91">Balemans et al 2002b</xref>, <xref ref-type="bibr" rid="sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</xref>].</p>
          <p><bold>Sclerosteosis.</bold> The diagnosis of sclerosteosis is based on characteristic clinical and radiographic features and a family history consistent with autosomal recessive inheritance. </p>
          <p>Clinical features include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Generalized progressive skeletal overgrowth, most pronounced in the skull and mandible, leading to: </p>
              <list list-type="bullet">
                <list-item>
                  <p>Potentially lethal elevation of intracranial pressure in childhood or early adulthood as a result of calvarial overgrowth </p>
                </list-item>
                <list-item>
                  <p>Entrapment of the seventh cranial nerve leading to recurrent facial palsy that is initially intermittent and eventually constant, resulting in impaired facial movements in adulthood </p>
                </list-item>
                <list-item>
                  <p>Conductive hearing loss in childhood followed by additional entrapment of the eighth cranial nerve and closure of the oval and round windows, leading to sensorineural hearing loss in adulthood </p>
                </list-item>
                <list-item>
                  <p>Distortion of the face with asymmetric mandibular hypertrophy, frontal bossing, midface hypoplasia, and proptosis </p>
                </list-item>
                <list-item>
                  <p>Tall stature with accelerated bone growth beginning in childhood </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Variable cutaneous or bony syndactyly of fingers two (index) and three (middle), and occasionally fingers three and other fingers. The syndactyly is usually bilateral but not necessarily symmetric</p>
            </list-item>
            <list-item>
              <p>Radial deviation of the terminal phalanges </p>
            </list-item>
            <list-item>
              <p>Dysplastic or absent nails </p>
            </list-item>
          </list>
          <p>The majority of persons affected with sclerosteosis are members of the Afrikaner (Dutch ancestry) population of South Africa. The diagnosis should be suspected in any neonate in this population with syndactyly of the second and third fingers particularly in the presence of fluctuating facial palsy, which later may become permanent. </p>
          <p>Radiographic findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Widening (hyperostosis) and increased density (sclerosis) of the calvarium, the base of the skull, and the shafts of the tubular bones </p>
            </list-item>
            <list-item>
              <p>Undermodeling of the shafts of the tubular bones of the metacarpals and phalanges </p>
            </list-item>
            <list-item>
              <p>Broad and dense clavicles and ribs </p>
            </list-item>
            <list-item>
              <p>Sclerosis of the scapulae and pelvis without an increase in size </p>
            </list-item>
            <list-item>
              <p>Relative sparing of the spine [<xref ref-type="bibr" rid="sost.REF.beighton.1976.934">Beighton et al 1976</xref>, <xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al 2003</xref>] </p>
            </list-item>
          </list>
          <p><bold>Van Buchem disease.</bold> This disorder is milder than sclerosteosis. Neurologic complications are less common and syndactyly does not occur. </p>
        </sec>
        <sec id="sost.Testing">
          <title>Testing</title>
          <p>Serum concentration of calcium and phosphorus are normal in individuals with sclerosteosis and van Buchem disease. </p>
          <p>Serum concentration of alkaline phosphatase may be elevated.</p>
          <p>Urinary cross-linked N-telopeptide was significantly elevated in one study of six individuals with van Buchem disease [<xref ref-type="bibr" rid="sost.REF.wergedal.2003.5778">Wergedal et al 2003</xref>]. Serum procollagen peptide and osteocalcin concentrations were also significantly elevated in these individuals.</p>
          <p>Histologic examination of the bone reveals increased bone density with thicker than normal trabeculae and cortices. </p>
          <sec id="sost.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">SOST</italic> is the only gene in which mutations are known to cause sclerosteosis and van Buchem disease. </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sclerosteosis.</bold>
<italic toggle="yes">SOST</italic> mutations reported thus far in individuals with sclerosteosis: three distinct stop mutations in families of Afrikaner, Brazilian, and mixed descent (northern European/Native American/African American), a splicing mutation in an individual of African heritage from Senegal [<xref ref-type="bibr" rid="sost.REF.balemans.2001.537">Balemans et al 2001</xref>, <xref ref-type="bibr" rid="sost.REF.brunkow.2001.577">Brunkow et al 2001</xref>], and a missense mutation in siblings of Turkish stock [<xref ref-type="bibr" rid="sost.REF.piters.2010.E1526">Piters et al 2010</xref>] </p>
              </list-item>
              <list-item>
                <p><bold>Van Buchem disease.</bold>
<xref ref-type="bibr" rid="sost.REF.balemans.2002b.91">Balemans et al [2002b]</xref> and <xref ref-type="bibr" rid="sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al [2002]</xref> identified a 52-kb homozygous deletion downstream of <italic toggle="yes">SOST</italic> in all Dutch individuals with van Buchem disease studied to date. The deletion does not appear to overlap the coding region of <italic toggle="yes">SOST</italic> or any other gene and potentially results in reduced <italic toggle="yes">SOST</italic> transcription by <italic toggle="yes">cis</italic> regulatory action or a position effect. None of the Dutch individuals affected with van Buchem disease in these studies were found to have mutations within <italic toggle="yes">SOST</italic>. A putative disease-causing splicing mutation in <italic toggle="yes">SOST</italic> was found in a brother and sister of German origin who were diagnosed with van Buchem disease [<xref ref-type="bibr" rid="sost.REF.balemans.2005.943">Balemans et al 2005</xref>]. </p>
              </list-item>
            </list>
            <p><bold>Clinical testing</bold>
</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Targeted mutation analysis</bold> identifies the 52-kb deletion downstream of <italic toggle="yes">SOST</italic>. It is not clear what percentage of individuals with van Buchem disease (or potentially sclerosteosis) have this mutation.</p>
              </list-item>
            </list>
            <table-wrap id="sost.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
              <label>Table 1.</label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">SOST</italic>-Related Sclerosing Bone Dysplasias</p>
              </caption>
              <table>
                <tbody>
                  <tr>
                    <th id="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1">
                      <italic toggle="yes">SOST</italic>
                    </td>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                  <tr>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis</td>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">52-kb deletion downstream of <italic toggle="yes">SOST</italic>&#x000a0;<sup>5</sup></td>
                    <td headers="hd_b_sost.T.summary_of_molecular_genetic_test_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="sost.TF.2">
                  <label>1.</label>
                  <p>See <related-object source-id="gene" document-id="sost" object-id="sost.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="sost.TF.2.1">
                  <label>2.</label>
                  <p>See <xref ref-type="sec" rid="sost.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
                </fn>
                <fn id="sost.TF.2.2">
                  <label>3.</label>
                  <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
                </fn>
                <fn id="sost.TF.2.3">
                  <label>4.</label>
                  <p>Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="sost.TF.2.4">
                  <label>5.</label>
                  <p><xref ref-type="bibr" rid="sost.REF.balemans.2002b.91">Balemans et al [2002b]</xref>, <xref ref-type="bibr" rid="sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al [2002]</xref></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sost.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To establish the diagnosis in a proband.</bold> Diagnosis is based on recognition of the characteristic clinical and radiologic manifestations, along with any relevant family data.</p>
          <p><bold>To confirm the diagnosis in a proband.</bold> Molecular genetic testing can be used, when available.</p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the disease-causing mutations in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="sost.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="sost.Natural_History">
          <title>Clinical Description</title>
          <p>Hypothesized to be allelic disorders [<xref ref-type="bibr" rid="sost.REF.beighton.1984.175">Beighton et al 1984</xref>], sclerosteosis and van Buchem disease were confirmed to be caused by mutations in the same gene in 2002 [<xref ref-type="bibr" rid="sost.REF.balemans.2002b.91">Balemans et al 2002b</xref>, <xref ref-type="bibr" rid="sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al 2002</xref>]. The manifestations of van Buchem disease are generally milder than those in sclerosteosis and syndactyly is absent (<xref ref-type="table" rid="sost.T.distinguishing_features_of_sclero">Table 2</xref>) [<xref ref-type="bibr" rid="sost.REF.beighton.1984.175">Beighton et al 1984</xref>].</p>
          <table-wrap id="sost.T.distinguishing_features_of_sclero" position="anchor" orientation="portrait">
            <label>Table 2.</label>
            <caption>
              <p>Distinguishing Features of Sclerosteosis and van Buchem Disease</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"/>
                  <th id="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sclerosteosis </th>
                  <th id="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">van Buchem Disease </th>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Reported cases</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">&#x000b1;80</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">&#x000b1;20</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Age of clinical presentation</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Early childhood</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Puberty</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Prognosis</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Potentially lethal</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Comparatively benign</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Habitus</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Gigantism </td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Normal stature</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Facies</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Gross distortion</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Prominent mandible</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Teeth</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Malaligned, with malocclusion </td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Normal</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Cranial nerve palsy</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Very common</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Inconsistent </td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Intracranial pressure</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Raised</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Inconsistent elevation</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Syndactyly</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Absent </td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Nail hypoplasia</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Cranial hyperostosis</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Gross</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Moderate</td>
                </tr>
                <tr>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1"><bold>Distortion of tubular bones of hands and feet</bold>
</td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Marked </td>
                  <td headers="hd_b_sost.T.distinguishing_features_of_sclero_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mild</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sost.TF.3">
                <p>From <xref ref-type="bibr" rid="sost.REF.beighton.1995.1">Beighton [1995]</xref>, p 234</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Sclerosteosis.</bold> The major clinical features of sclerosteosis are progressive skeletal overgrowth and variable syndactyly, usually of the second (index) and third (middle) fingers. Affected individuals appear normal at birth except for syndactyly (seen in 76%). The distinctive facial features are usually apparent by age five years. The risk for fractures, osteomyelitis, or bone marrow failure is not increased. </p>
          <p>Hyperostosis of the skull results in narrowing of the foramina, causing entrapment of the seventh cranial nerve often leading to facial palsy [<xref ref-type="bibr" rid="sost.REF.hamersma.2007.61">Hamersma &#x00026; Hofmeyr 2007</xref>]. Entrapment of the eighth cranial nerve resulting in deafness in mid-childhood occurs in 82% of affected individuals [<xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al 2003</xref>]. Anosmia may develop in adulthood. </p>
          <p>Asymmetric overgrowth of the mandible and malalignment of the teeth are common [<xref ref-type="bibr" rid="sost.REF.stephen.2001.287">Stephen et al 2001</xref>], occurring in 73% in one study [<xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al 2003</xref>]. Proptosis is common (25%).</p>
          <p>Hyperostosis of the calvarium reduces intracranial volume, leading to potentially lethal elevation of intracranial pressure. Affected individuals typically experience headache from brain compression. Sudden death can result from compression of the medulla at the level of the foramen magnum. Thus, even though the occipital frontal circumference (OFC) may be at the 95th centile, the intracranial volume is typically smaller than normal. The calvarial bone itself can be up to 3-4 cm thick.</p>
          <p>Dual x-ray absorptiometry in seven affected persons revealed markedly increased bone mineral density (BMD). In 18 phenotypically normal heterozygotes, the BMD was above the mean values of age-matched controls [<xref ref-type="bibr" rid="sost.REF.gardner.2005.6392">Gardner et al 2005</xref>].</p>
          <p>Survival into old age is unusual but not unprecedented [<xref ref-type="bibr" rid="sost.REF.barnard.1980.401">Barnard et al 1980</xref>]. Mean age of death is 33 years [<xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al 2003</xref>], but with increasing use of early craniectomy, longer term survival is likely. The natural history of sclerosteosis has been reviewed in <xref ref-type="bibr" rid="sost.REF.beighton.1988.200">Beighton [1988]</xref>, <xref ref-type="bibr" rid="sost.REF.beighton.1995.1">Beighton [1995]</xref>, and <xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al [2003]</xref>.</p>
          <p><bold>Van Buchem disease.</bold> Individuals with van Buchem disease have normal stature and no syndactyly. The course of the disorder is similar to that of sclerosteosis but generally milder. Facial distortion is less severe and the frequency of neurologic complications is lower. </p>
          <p><bold>Craniodiaphyseal dysplasia (CDD).</bold> In the autosomal dominant form of CDD (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/122860">122860</ext-link>) heterozygous <italic toggle="yes">SOST</italic> mutations have been documented in two affected children in Korea and Poland [<xref ref-type="bibr" rid="sost.REF.kim.2011.497">Kim et al 2011</xref>]. Details of the phenotype in the latter child had been published previously [<xref ref-type="bibr" rid="sost.REF.bieganski.2007.2435">Bieganski et al 2007</xref>]. The main phenotypic features are progressive overgrowth of the craniofacial bones with deafness, facial palsy, and visual disturbance as a result of nerve entrapment. Choanal stenosis is a clinically significant complication. Radiologically the cranial and facial bones are hyperostotic while the diaphyses of the limb bones are expanded with thin cortices. The authors suggested that this form of CDD was part of the spectrum that includes sclerosteosis and van Buchem disease. </p>
        </sec>
        <sec id="sost.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>If sclerosteosis, van Buchem disease, and CDD are regarded as a spectrum of disorders caused by mutations in <italic toggle="yes">SOST</italic> [<xref ref-type="bibr" rid="sost.REF.kim.2011.497">Kim et al 2011</xref>], the concept of genotype-phenotype correlation in this group of disorders is tenable.</p>
          <p>In CDD, <italic toggle="yes">SOST</italic> mutations are located in the secretion signal of the gene and prevented sclerostin secretion possibly by a dominant negative mechanism [<xref ref-type="bibr" rid="sost.REF.kim.2011.497">Kim et al 2011</xref>]. </p>
        </sec>
        <sec id="sost.Nomenclature">
          <title>Nomenclature</title>
          <p>In the past, sclerosteosis and van Buchem disease have been grouped with other dense bone disorders under nonspecific general terms including marble bones, osteopetrosis, and Albers-Sch&#x000f6;nberg disease. Diagnostic precision and syndromic delineation followed and the term "sclerosteosis" became established. Similarly, van Buchem and his colleagues employed the designation "hyperostosis corticalis generalisata familiaris" for the condition that is now known as "van Buchem disease."</p>
          <p>In the nosology of the dense bone disorders, sclerosteosis and van Buchem disease have been categorized as "craniotubular hyperostoses." With the elucidation of the molecular basis of these conditions, they are now classified together as <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias.</p>
        </sec>
        <sec id="sost.Prevalence">
          <title>Prevalence</title>
          <p><bold>Sclerosteosis.</bold> During the last 40 years, sclerosteosis has been recognized in more than 70 persons in the Afrikaner (Dutch ancestry) community of South Africa [<xref ref-type="bibr" rid="sost.REF.beighton.1979.783">Beighton &#x00026; Hamersma 1979</xref>, <xref ref-type="bibr" rid="sost.REF.hamersma.2003.192">Hamersma et al 2003</xref>]. In the Afrikaner population of South Africa, the carrier rate for the single founder-derived mutation is approximately one in 100 [<xref ref-type="bibr" rid="sost.REF.gardner.1999.1">Gardner 1999</xref>]. </p>
          <p>Simplex cases (i.e., a single affected individual in a family) or occurrences of familial sclerosteosis have been recorded in the following populations:</p>
          <list list-type="bullet">
            <list-item>
              <p>United States [<xref ref-type="bibr" rid="sost.REF.higinbotham.1941.444">Higinbotham &#x00026; Alexander 1941</xref>, <xref ref-type="bibr" rid="sost.REF.kelley.1946.507">Kelley &#x00026; Lawlah 1946</xref>, <xref ref-type="bibr" rid="sost.REF.stein.1983.267">Stein et al 1983</xref>] </p>
            </list-item>
            <list-item>
              <p>Germany [<xref ref-type="bibr" rid="sost.REF.pietruschka.1958.509">Pietruschka 1958</xref>] </p>
            </list-item>
            <list-item>
              <p>Japan [<xref ref-type="bibr" rid="sost.REF.sugiura.1975.273">Sugiura &#x00026; Yasuhara 1975</xref>] </p>
            </list-item>
            <list-item>
              <p>Brazil [<xref ref-type="bibr" rid="sost.REF.freiredepaesalves.1982.825">Freire de Paes Alves et al 1982</xref>, <xref ref-type="bibr" rid="sost.REF.kim.2008.475">Kim et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Spain [<xref ref-type="bibr" rid="sost.REF.bueno.1994.976">Bueno et al 1994</xref>] </p>
            </list-item>
            <list-item>
              <p>Senegal [<xref ref-type="bibr" rid="sost.REF.tacconi.1998.497">Tacconi et al 1998</xref>] </p>
            </list-item>
            <list-item>
              <p>Greek Cypriot [<xref ref-type="bibr" rid="sost.REF.itin.2001.259">Itin et al 2001</xref>] </p>
            </list-item>
            <list-item>
              <p>Turkey [<xref ref-type="bibr" rid="sost.REF.piters.2010.E1526">Piters et al 2010</xref>]</p>
            </list-item>
          </list>
          <p><bold>Van Buchem disease.</bold> Van Buchem disease has been recognized predominantly in the Dutch population (&#x000b1;20 cases). Several of the affected families have ancestral origins on the former island of Urk in the Zuider Zee. In addition, a brother and sister of German origin with a possible diagnosis of van Buchem disease were described [<xref ref-type="bibr" rid="sost.REF.balemans.2005.943">Balemans et al 2005</xref>]. </p>
          <p><bold>Craniodiaphyseal dysplasia (CDD).</bold> The two children reported to date with <italic toggle="yes">SOST</italic>-related CDD were from Korea and Poland [<xref ref-type="bibr" rid="sost.REF.kim.2011.497">Kim et al 2011</xref>]. </p>
        </sec>
      </sec>
      <sec id="sost.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Apart from sclerosteosis, van Buchem disease, and craniodiaphyseal dysplasia, no other simple genetic disorders are known to be associated with mutations in <italic toggle="yes">SOST</italic>. However, common non-coding polymorphisms in the gene were found to moderately affect bone mineral density in the elderly, suggesting a role for the product encoded by <italic toggle="yes">SOST</italic> in the complex disorder, osteoporosis [<xref ref-type="bibr" rid="sost.REF.uitterlinden.2004.1032">Uitterlinden et al 2004</xref>].</p>
      </sec>
      <sec id="sost.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Sclerosteosis, van Buchem disease and craniodiaphyseal dysplasia are included in the category of craniotubular hyperostoses, which need to be distinguished from other sclerosing bone dysplasias. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>The osteoscleroses, notably osteopetrosis, characterized by increased bone density with no bone overgrowth and little or no disturbance of the contours of the bones; and </p>
          </list-item>
          <list-item>
            <p>The craniotubular dysplasias, characterized by abnormal modeling of the skeleton and moderate sclerosis of the calvarium and base of the skull. </p>
          </list-item>
        </list>
        <p>The predominant feature of the craniotubular hyperostoses is overgrowth of bone, which leads to alterations of contours and increase in radiologic density of the skeleton. The bones are often very resistant to trauma. In addition to sclerosteosis and van Buchem disease, this group of disorders includes: </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Endosteal hyperostosis, Worth form.</bold> This much milder disorder is inherited in an autosomal dominant manner and can be caused by mutation in <italic toggle="yes">LRP5</italic>. Affected individuals may develop palsies of the seventh and eighth cranial nerves, together with enlargement of the mandible and mild facial distortion, but are otherwise asymptomatic. Smooth bony swellings may be present on the palate (torus palatinus) as in sclerosteosis. </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ced" document-type="chapter"><bold>Camurati-Engelmann disease</bold></related-object>
<bold>(CED).</bold> CED (progressive diaphyseal dysplasia) is characterized by hyperostosis of the long bones and the skull, proximal muscle weakness, severe limb pain, and joint contractures. Frontal bossing, enlargement of the mandible, proptosis, and cranial nerve impingement resulting in facial palsy are seen in severe cases later in life. Diagnosis of CED is based on physical examination and radiographic findings and can be confirmed by molecular genetic testing. Bone and muscle histology are nonspecific. <italic toggle="yes">TGFB1</italic> is the only gene in which mutation is known to cause CED. Sequence analysis identifies mutations in <italic toggle="yes">TGFB1</italic> in about 90% of affected individuals. Inheritance is autosomal dominant. </p>
          </list-item>
          <list-item>
            <p><bold>Craniodiaphyseal dysplasia (CDD)</bold>. CDD is a severe progressive sclerosing bone dysplasia with maximal involvement of the craniofacial skeleton. Choanal stenosis is a potentially lethal manifestation. CDD is possibly heterogeneous. Mutations in <italic toggle="yes">SOST</italic> have been demonstrated in two unrelated affected children [<xref ref-type="bibr" rid="sost.REF.kim.2011.497">Kim et al 2011</xref>] (see <xref ref-type="sec" rid="sost.Clinical_Description">Clinical Characteristics</xref>).</p>
          </list-item>
        </list>
      </sec>
      <sec id="sost.Management">
        <title>Management</title>
        <sec id="sost.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Formal audiologic evaluation </p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation for consequences of cranial nerve entrapment </p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation for evidence of increased intracranial pressure and/or proptosis </p>
            </list-item>
            <list-item>
              <p>Assessment of the necessity for surgical correction of syndactyly in individuals with sclerosteosis </p>
            </list-item>
            <list-item>
              <p>Radiographic and imaging studies </p>
            </list-item>
            <list-item>
              <p>Dental assessment </p>
            </list-item>
          </list>
        </sec>
        <sec id="sost.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The bones in sclerosteosis are thick and dense; surgical intervention may be difficult and prolonged. Standard neurosurgical instruments may not be sufficient (i.e., drill bits may be too short and power tools may be damaged by the dense bone) [<xref ref-type="bibr" rid="sost.REF.duplessis.1993.388">du Plessis 1993</xref>]. In addition, bone regrowth occurs and may cause recurrence of symptoms. </p>
          <p>Management is based on surgical decompression of the entrapped cranial nerves that can cause recurrent facial paralysis similar to Bell's palsy (from age two years onwards). Trigeminal nerve decompression can help if facial pain is severe. </p>
          <p>Craniectomy is required if intracranial pressure becomes elevated (from age five years onwards but usually in young adulthood). In South Africa this procedure is undertaken at an increasingly younger age.</p>
          <p>Middle ear surgery to correct conductive hearing loss and the provision of hearing aids may be helpful. Brain stem implantation of electrodes is indicated if there is obliteration of the internal auricular canal and damage to the auditory nerve.</p>
          <p>Spinal cord decompression may occasionally be needed in adulthood to alleviate backache. </p>
          <p>Surgical correction of syndactyly may be necessary in early childhood in order to improve function and cosmetic appearance in those with sclerosteosis. </p>
          <p>Mandible reduction may be performed for cosmetic reasons or if mouth closure is impaired as a result of overgrowth of the mandible. Tooth extraction may be difficult. Management by an orthodontic or craniofacial team is recommended.</p>
        </sec>
        <sec id="sost.Surveillance">
          <title>Surveillance</title>
          <p>Annually from infancy onwards for the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Audiologic assessment </p>
            </list-item>
            <list-item>
              <p>Assessment for increased intracranial pressure and medullary compression </p>
            </list-item>
            <list-item>
              <p>Neurologic and otologic examination for consequences of cranial nerve entrapment </p>
            </list-item>
            <list-item>
              <p>Dental and orthodontic evaluation of tooth malalignment and malocclusion on an individual basis.</p>
            </list-item>
          </list>
        </sec>
        <sec id="sost.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical appraisal and lateral skull radiograph as indicated</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing of the parents if the <italic toggle="yes">SOST</italic> mutations have been identified in the proband</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="sost.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sost.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="sost.Other">
          <title>Other</title>
          <p>Surgery for proptosis has not been successful [<xref ref-type="bibr" rid="sost.REF.devilliers.1995.1">De Villiers &#x00026; du Plessis 1995</xref>]. </p>
        </sec>
      </sec>
      <sec id="sost.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sost.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Sclerosteosis and van Buchem disease are <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias which are inherited in an autosomal recessive manner. </p>
          <p><italic toggle="yes">SOST</italic>-related craniodiaphyseal dysplasia is inherited in an autosomal dominant manner. Since molecular investigations in only two cases have been reported to date, this mode of inheritance is yet to be confirmed. </p>
        </sec>
        <sec id="sost.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are heterozygotes (carriers). </p>
            </list-item>
            <list-item>
              <p>In sclerosteosis, some heterozygotes have calvarial widening. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of a proband has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. </p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with sclerosteosis or van Buchem disease are obligate heterozygotes (carriers) for a disease-causing mutation in <italic toggle="yes">SOST</italic>. </p>
            </list-item>
            <list-item>
              <p>If the reproductive partner of the proband is heterozygous for an <italic toggle="yes">SOST</italic> mutation, each offspring has a 50% chance of inheriting two copies of an <italic toggle="yes">SOST</italic> mutation and being affected. Reproductive partners are more likely to be carriers of an <italic toggle="yes">SOST</italic> mutation if they are related to the proband or are members of populations with a high carrier frequency. </p>
            </list-item>
            <list-item>
              <p><bold>Sclerosteosis.</bold> In the Afrikaner population of South Africa, the carrier rate is approximately 1:100. </p>
            </list-item>
            <list-item>
              <p><bold>Van Buchem disease.</bold> The Dutch population is the only population known to have an elevated carrier rate for mutations in <italic toggle="yes">SOST</italic>. </p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier. </p>
        </sec>
        <sec id="sost.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the disease-causing mutations in the family have been identified. </p>
        </sec>
        <sec id="sost.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="sost.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="sost.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> Prenatal diagnosis for pregnancies at increased risk is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis usually performed at approximately 15 to 18 weeks&#x02019; gestation or chorionic villus sampling (CVS) at approximately ten to 12 weeks&#x02019; gestation. The disease-causing mutations in the family must be identified before prenatal testing can be performed.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p><bold>Ultrasound examination.</bold> Ultrasound examination may be able to detect syndactyly in fetuses at risk for sclerosteosis. This finding is variable in sclerosteosis and therefore its presence in an at-risk fetus is indicative of SCL, but its absence is not indicative of an unaffected fetus. </p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutations have been identified. </p>
        </sec>
      </sec>
      <sec id="sost.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sost.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="sost.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Sclerosteosis is a disorder of bone modeling and remodeling, especially of the skull and diaphyseal region of the long bones. Current evidence supports a deficiency of sclerostin, a novel regulatory protein that is normally secreted from terminally differentiated cells embedded within a mineralized matrix, such as osteocytes, mineralized hypertrophic chondrocytes, and cementocytes [<xref ref-type="bibr" rid="sost.REF.winkler.2003.6267">Winkler et al 2003</xref>, <xref ref-type="bibr" rid="sost.REF.vanbezooijen.2004.805">van Bezooijen et al 2004</xref>, <xref ref-type="bibr" rid="sost.REF.poole.2005.1842">Poole et al 2005</xref>, <xref ref-type="bibr" rid="sost.REF.vanbezooijen.2009.569">van Bezooijen et al 2009</xref>] resulting in the increased bone density observed in sclerosteosis and van Buchem disease. Carriers (heterozygotes) of pathogenic <italic toggle="yes">SOST</italic> gene variants, while free of any clinical symptoms or complications of sclerosteosis, undergo the process of bone turnover and exhibit bone mineral densities at levels that are intermediate between normal and affected individuals, pointing to the body&#x02019;s exquisite sensitivity to absolute levels of sclerostin [<xref ref-type="bibr" rid="sost.REF.gardner.2005.6392">Gardner et al 2005</xref>, <xref ref-type="bibr" rid="sost.REF.vanlierop.2011.2804">van Lierop et al 2011</xref>]. </p>
          <p><bold>Benign allelic variants.</bold> Benign variants within the sclerostin signal sequence as well as in the non-coding sequence flanking the two-exon <italic toggle="yes">SOST</italic> gene have been reported [<xref ref-type="bibr" rid="sost.REF.balemans.2002a.515">Balemans et al 2002a</xref>, <xref ref-type="bibr" rid="sost.REF.uitterlinden.2004.1032">Uitterlinden et al 2004</xref>]. </p>
          <p><bold>Pathogenic allelic variants.</bold> Consistent with the autosomal recessive inheritance pattern of the disorder, all <italic toggle="yes">SOST</italic> mutations reported thus far result in loss of function of the gene product, by introduction of a termination codon, splice site mutations, or missense mutation [<xref ref-type="bibr" rid="sost.REF.balemans.2001.537">Balemans et al 2001</xref>, <xref ref-type="bibr" rid="sost.REF.brunkow.2001.577">Brunkow et al 2001</xref>, <xref ref-type="bibr" rid="sost.REF.balemans.2005.943">Balemans et al 2005</xref>, <xref ref-type="bibr" rid="sost.REF.piters.2010.E1526">Piters et al 2010</xref>]. A 52-kb downstream deletion potentially resulting in altered regulation of <italic toggle="yes">SOST</italic> was shown to be associated with van Buchem disease in Dutch individuals studied by <xref ref-type="bibr" rid="sost.REF.balemans.2002b.91">Balemans et al [2002b]</xref> and <xref ref-type="bibr" rid="sost.REF.staehlinghampton.2002.144">Staehling-Hampton et al [2002]</xref>. The inhibitory effect of this deletion on <italic toggle="yes">SOST</italic> expression was demonstrated in a transgenic mouse model [<xref ref-type="bibr" rid="sost.REF.loots.2005.928">Loots et al 2005</xref>]. See <related-object source-id="gene" document-id="sost" object-id="sost.molgen.TA">Table A</related-object>. </p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">SOST</italic> encodes a 213-amino acid propeptide (sclerostin) with a cystine-knot motif that participates in dimerization and receptor binding and a signal sequence for secretion. It was first described as a secreted bone morphogenetic protein (BMP) antagonist, thought to be derived from either osteoblasts/osteocytes after onset of mineralization [<xref ref-type="bibr" rid="sost.REF.winkler.2003.6267">Winkler et al 2003</xref>, <xref ref-type="bibr" rid="sost.REF.vanbezooijen.2004.805">Van Bezooijen et al 2004</xref>, <xref ref-type="bibr" rid="sost.REF.poole.2005.1842">Poole et al 2005</xref>] or from osteoclasts [<xref ref-type="bibr" rid="sost.REF.kusu.2003.24113">Kusu et al 2003</xref>]. For reviews, see <xref ref-type="bibr" rid="sost.REF.vanbezooijen.2005a.15">van Bezooijen et al [2005a]</xref>, <xref ref-type="bibr" rid="sost.REF.vanbezooijen.2005b.319">van Bezooijen et al [2005b]</xref>, and <xref ref-type="bibr" rid="sost.REF.moester.2010.99">Moester et al [2010]</xref>. </p>
          <p>Sclerostin has been shown to dimerize with the BMP antagonist noggin, suggesting an efficient mechanism for the fine-tuning of BMP activity and bone formation [<xref ref-type="bibr" rid="sost.REF.winkler.2004.36293">Winkler et al 2004</xref>]. </p>
          <p>One study found that expression of sclerostin effected apoptosis of osteoblasts in a differentiating culture [<xref ref-type="bibr" rid="sost.REF.sutherland.2004a.828">Sutherland et al 2004a</xref>]. More recent evidence points to a major role for sclerostin in regulating bone growth via down-modulation of Wnt signaling through its association with the Wnt co-receptors LRP5 and LRP6 [<xref ref-type="bibr" rid="sost.REF.li.2005.19883">Li et al 2005</xref>, <xref ref-type="bibr" rid="sost.REF.semenov.2005.26770">Sem&#x000eb;nov et al 2005</xref>]. The expression of SOST is positively influenced by the presence of specific BMPs [<xref ref-type="bibr" rid="sost.REF.ohyama.2004.4685">Ohyama et al 2004</xref>, <xref ref-type="bibr" rid="sost.REF.sutherland.2004b.448">Sutherland et al 2004b</xref>] and may be a direct target of the osteoblast-specific transcription factor Cbfa1/RUNX2 (see <related-object link-type="booklink" source-id="gene" document-id="ccd" document-type="chapter">Cleidocranial Dysplasia</related-object>) [<xref ref-type="bibr" rid="sost.REF.sevetson.2004.13849">Sevetson et al 2004</xref>]. </p>
          <p>Osteocytes are thought to be involved in mechanosensing and initiation of the bone anabolic response to mechanical loading; interestingly, expression of <italic toggle="yes">SOST</italic> in these cells decreases with loading and increases with unloading, suggesting a role for Wnt signaling in response to mechanical loading [<xref ref-type="bibr" rid="sost.REF.robling.2008.5866">Robling et al 2008</xref>, <xref ref-type="bibr" rid="sost.REF.lin.2009.1651">Lin et al 2009</xref>, <xref ref-type="bibr" rid="sost.REF.moustafa.2009.930">Moustafa et al 2009</xref>].</p>
          <p><bold>Abnormal gene product.</bold> The type of mutations in <italic toggle="yes">SOST</italic> suggests loss of function of the gene product.</p>
        </sec>
      </sec>
      <sec id="sost.References">
        <title>References</title>
        <sec id="sost.Literature_Cited">
          <title>Literature Cited </title>
          <ref-list id="sost.Literature_Cited.reflist0">
            <ref id="sost.REF.balemans.2005.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleiren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebers</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W.</given-names>
                  </name>
                </person-group>
                <article-title>A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.</article-title>
                <source>Bone.</source>
                <year>2005</year>
                <volume>36</volume>
                <fpage>943</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15869924</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.balemans.2001.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebeling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dioszegi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacza</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuyts</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Ende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paes-Alves</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tacconi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dikkers</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindpaintner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vickery</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foernzler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).</article-title>
                <source>Hum Mol Genet.</source>
                <year>2001</year>
                <volume>10</volume>
                <fpage>537</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11181578</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.balemans.2002a.515">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foernzler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebeling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindpaintner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms.</article-title>
                <source>Bone.</source>
                <year>2002a</year>
                <volume>31</volume>
                <fpage>515</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12398949</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.balemans.2002b.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebeling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuyts</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacza</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dioszegi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dikkers</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildering</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willems</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheij</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindpaintner</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vickery</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foernzler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.</article-title>
                <source>J Med Genet.</source>
                <year>2002b</year>
                <volume>39</volume>
                <fpage>91</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11836356</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.barnard.1980.401">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barnard</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretzmar</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis in old age.</article-title>
                <source>S Afr Med J.</source>
                <year>1980</year>
                <volume>58</volume>
                <fpage>401</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">7404164</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.beighton.1988.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis.</article-title>
                <source>
                  <italic toggle="yes">J Med Genet</italic>
                </source>
                <year>1988</year>
                <volume>25</volume>
                <fpage>200</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">3351908</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.beighton.1995.1">
              <mixed-citation publication-type="book">Beighton P. Sclerosteosis. In: Donnai D, Winter RM, eds. <italic toggle="yes">Congenital Malformation Syndromes</italic>. London, UK: Chapman and Hall Medical Books Ltd; 1995:230-5. </mixed-citation>
            </ref>
            <ref id="sost.REF.beighton.1984.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Wouden</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>The syndromic status of sclerosteosis and van Buchem disease.</article-title>
                <source>Clin Genet.</source>
                <year>1984</year>
                <volume>25</volume>
                <fpage>175</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">6323069</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.beighton.1976.934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremin</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>The radiology of sclerosteosis.</article-title>
                <source>Br J Radiol.</source>
                <year>1976</year>
                <volume>49</volume>
                <fpage>934</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">188507</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.beighton.1979.783">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis in South Africa.</article-title>
                <source>S Afr Med J.</source>
                <year>1979</year>
                <volume>55</volume>
                <fpage>783</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">223247</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.bieganski.2007.2435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bieganski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baranska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miastkowska</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobielski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorska-Chrzastek</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>A boy with severe craniodiaphyseal dysplasia and apparently normal mother.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>2435</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">17853455</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.brunkow.2001.577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brunkow</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Ness</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paeper</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovacevich</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proll</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skonier</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabo</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alisch</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillett</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colbert</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tacconi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulligan</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2001</year>
                <volume>68</volume>
                <fpage>577</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">11179006</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.bueno.1994.976">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bueno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliv&#x000e1;n</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim&#x000e9;nez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garagorri</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarr&#x000ed;a</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueno</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bueno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>FJ</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin.</article-title>
                <source>J Med Genet.</source>
                <year>1994</year>
                <volume>31</volume>
                <fpage>976</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">7891385</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.devilliers.1995.1">
              <mixed-citation publication-type="book">De Villiers JC, du Plessis JJ. Neurosurgical management of sclerosteosis. In: Schmidek HM, Sweet WH, eds. <italic toggle="yes">Operative Neurosurgical Techniques</italic>. 3 ed, Vol 2. Philadelphia, PA: WB Saunders Co; 1995:2141-52.</mixed-citation>
            </ref>
            <ref id="sost.REF.duplessis.1993.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>du Plessis</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis: neurosurgical experience with 14 cases.</article-title>
                <source>J Neurosurg.</source>
                <year>1993</year>
                <volume>78</volume>
                <fpage>388</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">8433139</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.freiredepaesalves.1982.825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freire de Paes Alves</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>JLC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardoso</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabelo</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis: a marker of Dutch ancestry?.</article-title>
                <source>Rev Brasil Genet</source>
                <year>1982</year>
                <volume>4</volume>
                <fpage>825</fpage>
                <lpage>34</lpage>
              </element-citation>
            </ref>
            <ref id="sost.REF.gardner.1999.1">
              <mixed-citation publication-type="book">Gardner JC. <italic toggle="yes">Profound childhood deafness in South Africa: A clinical and molecular genetic approach</italic>. Cape Town, South Africa: University of Cape Town; 1999. </mixed-citation>
            </ref>
            <ref id="sost.REF.gardner.2005.6392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mervis</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdy</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Bone mineral density in sclerosteosis; affected individuals and gene carriers.</article-title>
                <source><italic toggle="yes">J</italic> Clin Endocrinol Metab.</source>
                <year>2005</year>
                <volume>90</volume>
                <fpage>6392</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16189254</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.hamersma.2003.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>The natural history of sclerosteosis.</article-title>
                <source>Clin Genet.</source>
                <year>2003</year>
                <volume>63</volume>
                <fpage>192</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12694228</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.hamersma.2007.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmeyr</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Too much bone: the middle ear in sclerosing bone dysplasias.</article-title>
                <source>Adv Otorhinolaryngol.</source>
                <year>2007</year>
                <volume>65</volume>
                <fpage>61</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17245025</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.higinbotham.1941.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Higinbotham</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Osteopetrosis: four cases in one family.</article-title>
                <source>Am J Surg.</source>
                <year>1941</year>
                <volume>53</volume>
                <fpage>444</fpage>
                <lpage>54</lpage>
              </element-citation>
            </ref>
            <ref id="sost.REF.itin.2001.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itin</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keser&#x000fc;</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauser</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Syndactyly/brachyphalangy and nail dysplasias as marker lesions for sclerosteosis.</article-title>
                <source>Dermatology.</source>
                <year>2001</year>
                <volume>202</volume>
                <fpage>259</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11385236</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.kelley.1946.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawlah</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>Albers-Sch&#x000f6;nberg disease; a family survey.</article-title>
                <source>Radiology.</source>
                <year>1946</year>
                <volume>47</volume>
                <fpage>507</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">20274620</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.kim.2008.475">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honjo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertola</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliveira</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jales</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siqueira</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castilho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piters</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jennes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.</article-title>
                <source>Genet Test.</source>
                <year>2008</year>
                <volume>12</volume>
                <fpage>475</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19072561</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.kim.2011.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bieganski</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sohn</surname>
                    <given-names>YB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sem&#x000eb;nov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahn</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ki</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>OH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>DK</given-names>
                  </name>
                </person-group>
                <article-title>Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.</article-title>
                <source>Hum Genet.</source>
                <year>2011</year>
                <volume>129</volume>
                <fpage>497</fpage>
                <lpage>502</lpage>
                <pub-id pub-id-type="pmid">21221996</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.kusu.2003.24113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kusu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurikkala</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imanishi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Usui</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konishi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thesleff</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>N.</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.</article-title>
                <source>J Biol Chem.</source>
                <year>2003</year>
                <volume>278</volume>
                <fpage>24113</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12702725</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.li.2005.19883">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.</article-title>
                <source>J Biol Chem.</source>
                <year>2005</year>
                <volume>280</volume>
                <fpage>19883</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15778503</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.lin.2009.1651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weng</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2009</year>
                <volume>24</volume>
                <fpage>1651</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">19419300</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.loots.2005.928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Loots</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kneissel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baptist</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collette</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ovcharenko</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plajzer-Frick</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.</article-title>
                <source>Genome Res.</source>
                <year>2005</year>
                <volume>15</volume>
                <fpage>928</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15965026</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.moester.2010.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moester</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin: current knowledge and future perspectives.</article-title>
                <source>Calcif Tissue Int.</source>
                <year>2010</year>
                <volume>87</volume>
                <fpage>99</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">20473488</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.moustafa.2009.930">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moustafa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saxon</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunters</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javaheri</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanyon</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <article-title>The mouse fibula as a suitable bone for the study of functional adaptation to mechanical loading.</article-title>
                <source>
                  <italic toggle="yes">Bone</italic>
                </source>
                <year>2009</year>
                <volume>44</volume>
                <fpage>930</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19442626</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.ohyama.2004.4685">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nifuji</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amagasa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noda</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.</article-title>
                <source>
                  <italic toggle="yes">Endocrinology</italic>
                </source>
                <year>2004</year>
                <volume>145</volume>
                <fpage>4685</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">15217980</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.pietruschka.1958.509">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pietruschka</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Further information on marble bones (Albers-Sch&#x000f6;nberg disease) with remarks on differential diagnosis.</article-title>
                <source>Klin Monbl Augenheilkd Augenarztl Fortbild.</source>
                <year>1958</year>
                <volume>132</volume>
                <fpage>509</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">13550791</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.piters.2010.E1526">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piters</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Culha</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moester</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Bezooijen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adriaensen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weidauer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jennes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Freitas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmermans</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.</article-title>
                <source>Hum Mutat.</source>
                <year>2010</year>
                <volume>31</volume>
                <fpage>E1526</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">20583295</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.poole.2005.1842">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poole</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loveridge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeve</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.</article-title>
                <source>FASEB J.</source>
                <year>2005</year>
                <volume>19</volume>
                <fpage>1842</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16123173</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.robling.2008.5866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robling</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niziolek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldridge</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Condon</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alam</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantila</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gluhak-Heinrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellido</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <article-title>Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.</article-title>
                <source>J Biol Chem.</source>
                <year>2008</year>
                <volume>283</volume>
                <fpage>5866</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">18089564</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.semenov.2005.26770">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sem&#x000eb;nov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X.</given-names>
                  </name>
                </person-group>
                <article-title>SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.</article-title>
                <source>J Biol Chem.</source>
                <year>2005</year>
                <volume>280</volume>
                <fpage>26770</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15908424</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.sevetson.2004.13849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sevetson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST).</article-title>
                <source>J Biol Chem.</source>
                <year>2004</year>
                <volume>279</volume>
                <fpage>13849</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">14739291</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.staehlinghampton.2002.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Staehling-Hampton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proll</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paeper</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charmley</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galas</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatzman</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunkow</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.</article-title>
                <source>Am J Med Genet.</source>
                <year>2002</year>
                <volume>110</volume>
                <fpage>144</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12116252</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.stein.1983.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witkop</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fallon</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viernstein</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gucer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeever</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Long</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teitelbaum</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship.</article-title>
                <source>Neurology.</source>
                <year>1983</year>
                <volume>33</volume>
                <fpage>267</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">6681869</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.stephen.2001.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stephen</surname>
                    <given-names>LX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Dental and oral manifestations of sclerosteosis.</article-title>
                <source>Int Dent J.</source>
                <year>2001</year>
                <volume>51</volume>
                <fpage>287</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11570544</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.sugiura.1975.273">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugiura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuhara</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis. A case report.</article-title>
                <source>J Bone Joint Surg Am.</source>
                <year>1975</year>
                <volume>57</volume>
                <fpage>273</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">163261</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.sutherland.2004a.828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geoghegan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turcott</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skonier</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkler</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latham</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.</article-title>
                <source>Bone.</source>
                <year>2004a</year>
                <volume>35</volume>
                <fpage>828</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">15454089</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.sutherland.2004b.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geoghegan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkler</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latham</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.</article-title>
                <source>Bone.</source>
                <year>2004b</year>
                <volume>35</volume>
                <fpage>448</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">15268896</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.tacconi.1998.497">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tacconi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrigno</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cocco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamburini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergonzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giagheddu</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Sclerosteosis: report of a case in a black African man.</article-title>
                <source>Clin Genet.</source>
                <year>1998</year>
                <volume>53</volume>
                <fpage>497</fpage>
                <lpage>501</lpage>
                <pub-id pub-id-type="pmid">9712543</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.uitterlinden.2004.1032">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uitterlinden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arp</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paeper</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charmley</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Proll</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivadeneira</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Meurs</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britschgi</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latham</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatzman</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pols</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunkow</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <article-title>Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2004</year>
                <volume>75</volume>
                <fpage>1032</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">15514891</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.vanbezooijen.2009.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bronckers</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gortzak</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogendoorn</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Wee-Pals</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostenbroek</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dikkers</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdy</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin in mineralized matrices and van Buchem disease.</article-title>
                <source>J Dent Res.</source>
                <year>2009</year>
                <volume>88</volume>
                <fpage>569</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">19587164</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.vanbezooijen.2005a.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>Bone morphogenetic proteins and their antagonists: the sclerostin paradigm.</article-title>
                <source>J Endocrinol Invest.</source>
                <year>2005a</year>
                <volume>28</volume>
                <fpage>15</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16323824</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.vanbezooijen.2004.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roelen</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Wee-Pals</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wilt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karperien</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ten Dijke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.</article-title>
                <source>J Exp Med.</source>
                <year>2004</year>
                <volume>199</volume>
                <fpage>805</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">15024046</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.vanbezooijen.2005b.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>ten Dijke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;wik</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.</article-title>
                <source>Cytokine Growth Factor Rev.</source>
                <year>2005b</year>
                <volume>16</volume>
                <fpage>319</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">15869900</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.vanlierop.2011.2804">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Lierop</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamdy</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bezooijen</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Power</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loveridge</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papapoulos</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.</article-title>
                <source>J Bone Miner Res.</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>2804</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">21786318</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.wergedal.2003.5778">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wergedal</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veskovic</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nyght</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libanati</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhoenacker</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baylink</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal.</article-title>
                <source>J Clin Endocrinol Metab.</source>
                <year>2003</year>
                <volume>88</volume>
                <fpage>5778</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">14671168</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.winkler.2003.6267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winkler</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geoghegan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayes</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skonier</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shpektor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovacevich</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staehling-Hampton</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleby</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunkow</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latham</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.</article-title>
                <source>EMBO J.</source>
                <year>2003</year>
                <volume>22</volume>
                <fpage>6267</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">14633986</pub-id>
              </element-citation>
            </ref>
            <ref id="sost.REF.winkler.2004.36293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Winkler</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geoghegan</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ojala</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skonier</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shpektor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latham</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex.</article-title>
                <source>J Biol Chem.</source>
                <year>2004</year>
                <volume>279</volume>
                <fpage>36293</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15199066</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sost.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sost.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Peter Beighton is the grateful recipient of support from the Medical Research Council and the National Research Foundation of South Africa.</p>
        </sec>
        <sec id="sost.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>10 January 2013 (cd) Revision: prenatal testing for <italic toggle="yes">SOST</italic> mutations available clinically</p>
            </list-item>
            <list-item>
              <p>12 January 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 October 2007 (cd) Revision: sequence analysis available on a clinical basis </p>
            </list-item>
            <list-item>
              <p>2 February 2007 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>23 September 2004 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>4 June 2002 (tk/me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>5 February 2002 (phb) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
